Cargando…

Comparing neurological complications after COVID-19 vaccination and SARS-CoV-2 infection

Detalles Bibliográficos
Autor principal:	Flemming, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569501/ https://www.ncbi.nlm.nih.gov/pubmed/34741166 http://dx.doi.org/10.1038/s41577-021-00655-3

Ejemplares similares

Intracranial inflammatory mediators involved in SARS-CoV-2 neurological manifestations?
por: Flemming, Alexandra
Publicado: (2021)

Cross-reactive memory T cells abort SARS-CoV-2 infection
por: Flemming, Alexandra
Publicado: (2021)

SARS-CoV-2 variant evades antibodies whilst maintaining fitness
por: Flemming, Alexandra
Publicado: (2021)

SARS-CoV-2 Delta variant excels at membrane fusion, but not immune evasion
por: Flemming, Alexandra
Publicado: (2021)

Foetal sex affects maternal and placental immune responses to SARS-CoV-2
por: Flemming, Alexandra
Publicado: (2021)

‘Prime and spike’ induces mucosal immunity and reduces SARS-CoV-2 transmission
por: Flemming, Alexandra
Publicado: (2022)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
por: Patone, Martina, et al.
Publicado: (2021)

Defective viral genomes can protect against SARS-CoV-2 variants and other respiratory viruses
por: Flemming, Alexandra
Publicado: (2021)

Long-term neurological sequelae of SARS-CoV-2 infection
Publicado: (2022)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

Severe Neurologic Complications of SARS-CoV-2
por: Sisniega, Daniella C., et al.
Publicado: (2021)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Cross-reactive tissue-resident CD8(+) T cells may provide first line of defence against SARS-CoV-2
por: Flemming, Alexandra
Publicado: (2021)

Publisher Correction: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
por: Patone, Martina, et al.
Publicado: (2021)

Neurological complications and infection mechanism of SARS-CoV-2
por: Wan, Dandan, et al.
Publicado: (2021)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina
por: Uschner, Diane, et al.
Publicado: (2022)

Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications
por: Khalefah, Muad M., et al.
Publicado: (2020)

Neurological infection and complications of SARS-CoV-2: A review
por: Singh, Santosh, et al.
Publicado: (2023)

Anti-SARS-CoV-2 vaccine in liver transplantation
por: Kotsiliti, Eleni
Publicado: (2022)

SARS-CoV-2 vaccine safe for young patients
por: Onuora, Sarah
Publicado: (2022)

Coagulation factor inhibitors in COVID‐19: From SARS‐CoV‐2 vaccination to infection
por: Jacobs, Jeremy W., et al.
Publicado: (2022)

Does SARS-CoV-2 infection cause chronic neurological complications?
por: Hascup, Erin R., et al.
Publicado: (2020)

Radiological Manifestation of Neurological Complications in the Course of SARS-CoV-2 Infection
por: Sklinda, Katarzyna, et al.
Publicado: (2021)

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
por: Konstantinidis, Theocharis G., et al.
Publicado: (2021)

SARS-CoV-2 vaccine — think globally, act locally
por: Gea-Mallorquí, Ester, et al.
Publicado: (2020)

Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece
por: Malli, Foteini, et al.
Publicado: (2023)

COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients
por: Angioni, Roberta, et al.
Publicado: (2022)

Spatial resolution of SARS-CoV-2 lung infection
por: Pia, Luisanna
Publicado: (2020)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
por: Lachant, Daniel J., et al.
Publicado: (2020)

Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
por: Finsterer, Josef
Publicado: (2023)

Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation
por: Sherman, Amy C., et al.
Publicado: (2023)

Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
por: Du, Zhanwei, et al.
Publicado: (2022)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications
por: Kalra, Rajkumar Singh, et al.
Publicado: (2021)

Clomipramine Could Be Useful in Preventing Neurological Complications of SARS-CoV-2 Infection
por: Nobile, B., et al.
Publicado: (2020)

Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b5fuuf0gdj4usgfpci64decu36